Promoting evidence-based management of anemia in cancer patients: Background, development, and scientific validation of RESPOND, a web-based clinical guidance system based on the EORTC guidelines

Matti Aapro, Joanna Van Erps, Karen MacDonald, Pierre Soubeyran, Matthew Turner, Michael Muenzberg, Robert Dunlop, Hans Warrinnier, Ivo L Abraham

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The 2006 EORTC guidelines for erythropoietic proteins in cancer-related anemia provide the most up-to-date assessment of the evidence base. Considering general concerns in medicine about clinicians' adoption of evidence-based guidelines, it is critical to find ways of bringing guidelines to the point of care. We describe the rationale behind RESPOND, a web-based clinical guidance system based on the EORTC guidelines, and the methodologies of two studies conducted to validate the system. In a first descriptive study, experts are asked to rate the accuracy of every algorithm derived from the guidelines. In a second step and using a hybrid matched pre-post design, separate retrospective and prospective patient cohorts matched by type of cancer and similarity of chemotherapy regimen (33 pairs) are used to examine the extent to which clinicians' practice patterns converge with the EORTC guidelines when they use or not use the RESPOND system. It is hypothesized that these studies will provide the necessary validation for RESPOND as an evidence-based clinical support tool.

Original languageEnglish (US)
Pages (from-to)32-42
Number of pages11
JournalCritical Reviews in Oncology/Hematology
Volume65
Issue number1
DOIs
StatePublished - Jan 2008
Externally publishedYes

Fingerprint

Anemia
Guidelines
Neoplasms
Point-of-Care Systems
Medicine
Drug Therapy
Proteins

Keywords

  • Anemia
  • Cancer
  • Decision-support systems
  • Erythropoietic proteins
  • Treatment guidelines
  • Validation

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Promoting evidence-based management of anemia in cancer patients : Background, development, and scientific validation of RESPOND, a web-based clinical guidance system based on the EORTC guidelines. / Aapro, Matti; Van Erps, Joanna; MacDonald, Karen; Soubeyran, Pierre; Turner, Matthew; Muenzberg, Michael; Dunlop, Robert; Warrinnier, Hans; Abraham, Ivo L.

In: Critical Reviews in Oncology/Hematology, Vol. 65, No. 1, 01.2008, p. 32-42.

Research output: Contribution to journalArticle

Aapro, Matti ; Van Erps, Joanna ; MacDonald, Karen ; Soubeyran, Pierre ; Turner, Matthew ; Muenzberg, Michael ; Dunlop, Robert ; Warrinnier, Hans ; Abraham, Ivo L. / Promoting evidence-based management of anemia in cancer patients : Background, development, and scientific validation of RESPOND, a web-based clinical guidance system based on the EORTC guidelines. In: Critical Reviews in Oncology/Hematology. 2008 ; Vol. 65, No. 1. pp. 32-42.
@article{c7c79505e04044f183c82aa985342e2a,
title = "Promoting evidence-based management of anemia in cancer patients: Background, development, and scientific validation of RESPOND, a web-based clinical guidance system based on the EORTC guidelines",
abstract = "The 2006 EORTC guidelines for erythropoietic proteins in cancer-related anemia provide the most up-to-date assessment of the evidence base. Considering general concerns in medicine about clinicians' adoption of evidence-based guidelines, it is critical to find ways of bringing guidelines to the point of care. We describe the rationale behind RESPOND, a web-based clinical guidance system based on the EORTC guidelines, and the methodologies of two studies conducted to validate the system. In a first descriptive study, experts are asked to rate the accuracy of every algorithm derived from the guidelines. In a second step and using a hybrid matched pre-post design, separate retrospective and prospective patient cohorts matched by type of cancer and similarity of chemotherapy regimen (33 pairs) are used to examine the extent to which clinicians' practice patterns converge with the EORTC guidelines when they use or not use the RESPOND system. It is hypothesized that these studies will provide the necessary validation for RESPOND as an evidence-based clinical support tool.",
keywords = "Anemia, Cancer, Decision-support systems, Erythropoietic proteins, Treatment guidelines, Validation",
author = "Matti Aapro and {Van Erps}, Joanna and Karen MacDonald and Pierre Soubeyran and Matthew Turner and Michael Muenzberg and Robert Dunlop and Hans Warrinnier and Abraham, {Ivo L}",
year = "2008",
month = "1",
doi = "10.1016/j.critrevonc.2007.05.002",
language = "English (US)",
volume = "65",
pages = "32--42",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Promoting evidence-based management of anemia in cancer patients

T2 - Background, development, and scientific validation of RESPOND, a web-based clinical guidance system based on the EORTC guidelines

AU - Aapro, Matti

AU - Van Erps, Joanna

AU - MacDonald, Karen

AU - Soubeyran, Pierre

AU - Turner, Matthew

AU - Muenzberg, Michael

AU - Dunlop, Robert

AU - Warrinnier, Hans

AU - Abraham, Ivo L

PY - 2008/1

Y1 - 2008/1

N2 - The 2006 EORTC guidelines for erythropoietic proteins in cancer-related anemia provide the most up-to-date assessment of the evidence base. Considering general concerns in medicine about clinicians' adoption of evidence-based guidelines, it is critical to find ways of bringing guidelines to the point of care. We describe the rationale behind RESPOND, a web-based clinical guidance system based on the EORTC guidelines, and the methodologies of two studies conducted to validate the system. In a first descriptive study, experts are asked to rate the accuracy of every algorithm derived from the guidelines. In a second step and using a hybrid matched pre-post design, separate retrospective and prospective patient cohorts matched by type of cancer and similarity of chemotherapy regimen (33 pairs) are used to examine the extent to which clinicians' practice patterns converge with the EORTC guidelines when they use or not use the RESPOND system. It is hypothesized that these studies will provide the necessary validation for RESPOND as an evidence-based clinical support tool.

AB - The 2006 EORTC guidelines for erythropoietic proteins in cancer-related anemia provide the most up-to-date assessment of the evidence base. Considering general concerns in medicine about clinicians' adoption of evidence-based guidelines, it is critical to find ways of bringing guidelines to the point of care. We describe the rationale behind RESPOND, a web-based clinical guidance system based on the EORTC guidelines, and the methodologies of two studies conducted to validate the system. In a first descriptive study, experts are asked to rate the accuracy of every algorithm derived from the guidelines. In a second step and using a hybrid matched pre-post design, separate retrospective and prospective patient cohorts matched by type of cancer and similarity of chemotherapy regimen (33 pairs) are used to examine the extent to which clinicians' practice patterns converge with the EORTC guidelines when they use or not use the RESPOND system. It is hypothesized that these studies will provide the necessary validation for RESPOND as an evidence-based clinical support tool.

KW - Anemia

KW - Cancer

KW - Decision-support systems

KW - Erythropoietic proteins

KW - Treatment guidelines

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=36849074240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849074240&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2007.05.002

DO - 10.1016/j.critrevonc.2007.05.002

M3 - Article

C2 - 17570677

AN - SCOPUS:36849074240

VL - 65

SP - 32

EP - 42

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 1

ER -